Research Program at Vance Thompson Vision

Vance Thompson Vision is currently recruiting for the following studies. The descriptions below highlight which patients within your program might be good candidates for the treatment types currently under investigation by Vance Thompson Vision and monitored by the FDA. For questions about any of these trials please call our Director of Research Keeley Puls at 605.371.7075

 

Cataract Research 

ACUFOCUS

Enrolling -  Sioux Falls

Good Candidate: Patients 22 years of age and older with cataracts in both eyes.

About study: The purpose of this study is to determine if the IC-8 lens is safe and provides far, intermediate and near vision when compared to a standard monofocal or monofocal toric lens

Which eye: Both eyes in study.

How long is study: 1 year study

Number of visits: 12 visits over 1 year

Cost to patient: Insurance will be billed for a normal cataract surgery.

Compensation:  Subjects will be compensated for their participation in this study.

Co-management-  No co-management

Lead Contact- Sam Nielson  [email protected]     605-371-7049

 

RxSight LAL

Enrolling  - Sioux Falls

Good Candidate:  Patients 40-80 years of age  with cataract in both eyes who have had prior Lasik or PRK with clear ocular medium.

About study: The purpose of the study is to evaluate the safety and effectiveness of the LAL by comparing the results obtained with it to the results obtained with your eye implanted with the Sensar AR40e standard IOL

Which eye:  Both eyes in the study.

How long is study:  6 month study

Number of visits:   14 visits over 6 month

Cost to patient:  Insurance billed for normal cataract surgery.

Compensation:   Subjects will be compensated for their participation in this study.

Co-management: No co-management

Lead Contact: Melissa Holm    [email protected]   605-371-7081

 

Johnson & Johnson Ancora TIOL-205-STPA Study 

Enrolling- Sioux Falls

Good Candidate:  Subjects at least 22 years old who have cataracts in both eye and have a certain degree of astigmatism in at least one eye.

About study:  The purpose of this study is to evaluate the rate of bothersome visual symptoms and ongoing safety of the TECNIS Symfony Toric Extended Range of Vision intraocular lenses (IOLs).

How long is study:  6 months

Number of visits: a minimum of 9 study visits

Cost to patient: The IOLs implanted will be provided at no cost. Subject and/or  insurance company are responsible for the cost of your regular medical care as well as all usual and customary costs related to your cataract surgeries and any glasses or contacts that may be needed postoperatively. 

Compensation:  Subjects will be compensated for their participation in this study.

Co-management:  No co-management

Lead Contact- Brooke Colby [email protected] 605-371-7068

 

Johnson and Johnson BRAVO  SUR-CAT-652-2001

Enrolling - Sioux Falls

Good Candidate: Patients 22 years of age and older with cataracts in both eyes.

About study:The purpose of this study is to evaluate the safety and effectiveness of a new investigational intraocular lens that is designed to give you good far, intermediate and near vision after your cataract surgery.

Which eye: Both eyes in study.

How long is study: 1 year study

Number of visits: 12 visits over 1 year

Cost to patient: You will not be charged for the IOLs implanted in both of your eyes. However, you or your insurance company are responsible for the cost of your regular medical care as well as costs related to your cataract surgeries

Compensation:  Subjects will be compensated for their participation in this study.

Co-management:  No co-management

Lead Contact- Sam Nielson  [email protected]     605-371-7049

 

Glaucoma Research

Glaukos GC-010 phase III FDA monitored clinical trial 

Enrolling - Sioux Falls, Fargo, Bozeman

Good Candidate: Patients that are ocular hypertensive or have mild to moderate glaucoma and will not need cataract surgery in the next three years or have had cataract surgery and no prior glaucoma surgery.

About study: To compare the safety and initial efficacy of intraocular implants containing travoprost at two different elution rates versus Timolol Maleate Ophthalmic Solution, USP, 0.5% (timolol) in reducing elevated intraocular pressure in subjects with open-angle glaucoma (OAG) or ocular hypertension (OHT).

Which eye:  Only one eye is eligible to participate in the study

How long is study:  3 year study

Number of visits:  16 visits over the 3 years

Cost to patient:  None

Compensation:  Subjects will be compensated for their participation in this study.

Co-management:  May co-manage non study eye if patient desires but we will watch both during the duration of the study as well.

Sioux Falls Lead Contact- Kristin Dunne [email protected]    605-371-7037 

OR Allie Winter [email protected] 605-371-8440

Fargo Lead Contact:  Angie Callahan [email protected] 701-566-5525 

Omaha Lead Contact:   Megan Boltjes  [email protected] 402-506-9969 

Bozeman Lead Contact:  Briana Parker [email protected]   406-219-0344

 

Allergan Bitmatoprost

Enrolling - SIOUX FALLS

 

Good Candidate:  Subjects  at least 18 years of age with a diagnosis of open angle glaucoma or ocular hypertension (high eye pressure) in your study eye that require eye pressure lowering medicine,  that in your study doctor’s opinion,is not adequately managed with topical medication due to side effects

About study:  The purpose of this study is to look into the safety and duration of effect of two dose strengths (10 μg and 15 μg) of Bimatoprost Sustained Release (SR) in the treatment ofglaucoma or ocular hypertension (high eye pressure).

How long is study:  approximately 32 months

Number of visits: there will be a total of 36 study visits over a period of approximately 32 months (includes up to a 10 day screening

period, up to a 42 day washout period, 18 months of a study treatment period followed by 12 months of extended follow up)

Cost to patient: It is not expected for there to be any costs for subjects  taking part in this study

Compensation:  Subjects will be compensated for their participation in this study.

Co-management-  No co-management

Lead Contact- Allie Winter [email protected]  605-371-7077

 

Sight Sciences Omni-Gemini 

Enrolling - Omaha, Fargo

Good Candidate: Patients 22 years of age and older with visually significant cataracts and open angle glaucoma.

About study: The purpose of this study is to assess the clinical effect of two procedures, performed using the OMNI Surgical System, and cataract surgery on eye pressure and glaucoma medications for people with glaucoma.

Which eye:   One eye

How long is study: 1 year

How many visits:  9 visits, possibly more

Cost to patient:  You or Your insurance will be billed for the study procedure, OMNI surgery + Cataract removal. All exams and tests that are required under this study and described in this consent form will be paid for by the study sponsor

Compensation:   Subjects will be compensated for their participation in this study.

Co-management:  No co-management

Fargo Lead Contact:  Angie Callaghan [email protected] 701-566-5525

Omaha Lead Contact:   Megan Boltjes  [email protected] 402-506-9969

 

Aphakic Research

None at this time.

Presbyopic Research

Allergan Presbyopia

Enrolling - Sioux Falls

Good Candidate:   Patients 40 to 55 years of age inclusive at the time of the screening visit who have a diagnosis of presbyopia.

About study:  The purpose of this study is to determine the safety and effectiveness of study treatment AGN-190584 in the treatment of presbyopia. Presbyopia is the normal loss of the ability to focus on near objects that occurs as we get older.

How long is study:  60 days

Number of visits:   6 visits over approximately 60 days.  Three visits are 10 hours visits each and three visits are 2-3 hours each.

Cost to patient: No cost to you for taking part in this study. The Sponsor will pay for study drug, tests, exams and medical procedures required by the study. All other items, including those related to the routine medical care, not required by the study shall be covered directly by you or your insurance company.

Compensation:  Subjects will be compensated for their participation in this study.

Co-management-  No co-management

Lead Contact- Samantha Nielson [email protected] 605-371-7049

Or Melissa Holm [email protected]   605-371-7081

Refractive Research

None at this time.

Dry Eye Research

Olympia TEAR Care System

Enrolling - Sioux Falls

Good Candidate: Adults over the age of 22 who has dry eye disease.

About study:  The purpose of this study is to evaluate the safety and effectiveness of the TearCare System in comparison to the LipiFlow System to treat dry eye disease.

How long is study:  1 month

Number of visits: 4-5 visits over 1 month. 

Cost to patient:  No cost to the patient or patient's insurance for participation

Compensation:  Subjects will be compensated for their participation in this study.

Co-management-  No co-management

Lead Contact- Jason Meyer [email protected] 605-371-7064

 

EyeGate OBG PE-042

Location:Sioux Falls

Good Candidate: Adults age 21-50 with dry eye and diagnosed with punctate epitheliopathies (PE). 

About study:  The purpose of this study is to evaluate the safety and performance of topical EyeGate Ocular Bandage Gel in patients with (PE).

How long is study:  2 weeks

Number of visits: 4 visits over 2 weeks.

Cost to patient: No Cost to the patient.

Compensation:  Subjects will be compensated for their participation in this study.

Co-management-  No co-management

Lead Contact- Jason Meyer [email protected]vancethompsonvision.com   605-371-7064

Cornea Research

Avedro Cross Linking ACP-KXL-401

Enrolling- Fargo, Bozeman

Good Candidate:   at least 18 years of age, have corneal ectasia after refractive surgery (such as LASIK, PRK, and planning to have corneal collagen cross-linking, or had cross-linking within the past 90 days.

About Study:  You may be eligible to take part in this observational registry study because you have been diagnosed with corneal ectasia after refractive surgery (such as LASIK or PRK) and you are planning, or have had, corneal collagen cross-linking procedure performed

Which eye:   One or both eyes

How long is study: 3 years

How many visits:  7 visits over 36 months.

Cost to patient:  You or your medical insurance company may be required to pay up to $6,750.00 for the cost of the treatment, medications prescribed by the study doctor during the course of the study, and for any additional standard medical care given during this research study.

Compensation: Subjects will be compensated for their participation in this study.

Co-management:   No co-management

Fargo Lead Contact: Angela Callaghan [email protected] 701-566-5525

Bozeman Lead Contact: Briana Parker [email protected]   406-219-0344

 

HEADACHE RESEARCH

None at this time.

 

closed to enrollment - ongoing studies

  • Sjogrens Dry Eye

  • Carl Zeiss Monofocal IOL

  • B+L Dvisc

  • B&L - Viscosurgical Device
  • Alcon UV-Femtosecond Laser Assisted Lenticular Extraction
  • Glaukos - GC-009
  • Glaukos - GC-007
  • Teton
  • Denali
  • Glaukos - PAS
  • Sonata 2
  • Alcon Toric IOL, ORA
  • Artisan Aphakia Lens
  • Advedro Crosslinking - Sioux Falls
  • Glaukos GC-011
  • DES/iStent